ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$10.85
-0.78%
Mkt Cap $2.57B
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (7 analysts)
$22.50
Range $21.00 – $24.00
Implied Upside
+107.5%
Consensus $22.50 vs current $10.85
NASDAQ·Healthcare·Biotechnology
$10.85
-0.78%
Mkt Cap $2.57B
Buy
1
Hold
1
Sell
0
Price Target (7 analysts)
$22.50
Range $21.00 – $24.00
+107.5%
Consensus $22.50 vs current $10.85